7-Chloro-5-methyl-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 95.0%, 5g

4,5-Dimethyl-2-phenyl-thiazole, 95.0%, 1g

1,2-Dibromo-4-iodobenzene>98.0%(GC)5g

Heptadecan-9-yl 8-bromooctanoate, 98%, 100mg

Nonadeca-4,6-diyn-1-ol, 95%, 500mg

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

TERT-BUTYL N-(3-FLUOROPIPERIDIN-4-YL)-N-METHYLCARBAMATE, 95.0%, 500mg

6-Methylisoquinolin-1(2H)-one, 97%, 100mg

tert-butyl 6-bromo-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate, 98%, 250mg

tert-butyl (3S)-3-({[(benzyloxy)carbonyl]amino}methyl)pyrrolidine-1-carboxylate, 97.0%, 1g

(1R,2R)-2-Fluorocyclopropan-1-amine hydrochloride, 98+%, 250mg

6-Bromo-2-ethoxy-3-(phenylmethyl)quinoline, 98%, 10mg

Narrow mouth bottle, 500 ml, 12 Piece(s)